IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

LAVAZZA, CRISTIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.400
NA - Nord America 1.325
AS - Asia 1.095
SA - Sud America 98
AF - Africa 38
OC - Oceania 2
Totale 3.958
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.295
GB - Regno Unito 468
CN - Cina 360
SG - Singapore 314
SE - Svezia 214
IT - Italia 165
DE - Germania 120
RU - Federazione Russa 112
HK - Hong Kong 99
VN - Vietnam 89
UA - Ucraina 86
NL - Olanda 66
BR - Brasile 61
TR - Turchia 55
IN - India 54
FR - Francia 48
KR - Corea 45
IE - Irlanda 44
FI - Finlandia 26
CI - Costa d'Avorio 23
BD - Bangladesh 22
CO - Colombia 20
CA - Canada 19
EU - Europa 18
JP - Giappone 16
BE - Belgio 14
PL - Polonia 14
IQ - Iraq 8
AR - Argentina 7
ID - Indonesia 6
MX - Messico 6
MY - Malesia 6
ZA - Sudafrica 5
DK - Danimarca 4
ES - Italia 3
KE - Kenya 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
AU - Australia 2
BG - Bulgaria 2
EG - Egitto 2
GT - Guatemala 2
IL - Israele 2
IR - Iran 2
PH - Filippine 2
SA - Arabia Saudita 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
EC - Ecuador 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
YT - Mayotte 1
Totale 3.976
Salva come PNG Salva come JPEG
Città #
Southend 417
Singapore 184
Chandler 138
Ashburn 117
Hong Kong 94
Beijing 89
Jacksonville 66
Milan 64
Seattle 58
Ann Arbor 51
Dallas 44
Dublin 43
Princeton 43
Santa Clara 43
Wilmington 41
Dearborn 37
San Jose 36
Mountain View 33
Bengaluru 32
Fairfield 32
New York 32
Woodbridge 32
Redmond 30
Los Angeles 28
Somerville 28
Council Bluffs 27
Abidjan 23
Hanoi 23
Nanjing 22
Des Moines 21
Guangzhou 20
Ho Chi Minh City 20
Lauterbourg 20
Boardman 19
Serra 19
Sakarya 18
Bogotá 17
Houston 16
Shanghai 16
Andover 15
Frankfurt am Main 15
Moscow 15
Phoenix 14
Tokyo 13
Brussels 12
The Dalles 12
Warsaw 12
Cambridge 11
Hefei 11
Shenyang 11
Buffalo 10
Columbus 10
Hanover 10
Nanchang 10
Toronto 10
Munich 9
Dong Ket 8
Jinan 8
Cangzhou 7
Genoa 7
Mumbai 7
Orem 7
Baghdad 6
Berlin 6
Falls Church 6
Hebei 6
Kunming 6
Tianjin 6
Chicago 5
Hangzhou 5
Ottawa 5
Seoul 5
São Paulo 5
Turin 5
Cagliari 4
Changsha 4
Helsinki 4
Jakarta 4
Quanzhou 4
Rozzano 4
Shenzhen 4
Sunnyvale 4
Washington 4
Wuhan 4
Auburn Hills 3
Bexley 3
Bitonto 3
Brooklyn 3
Haikou 3
Jiaxing 3
Johannesburg 3
Medford 3
Mexico City 3
Rio de Janeiro 3
San Francisco 3
Scranton 3
Tây Ninh 3
Verona 3
Amsterdam 2
Athens 2
Totale 2.489
Salva come PNG Salva come JPEG
Nome #
Finding a new therapeutic approach for no-option Parkinsonisms : Mesenchymal stromal cells for progressive supranuclear palsy 267
Targeting TRAIL Receptors with Genetically-Engineered CD34+ Hematopoietic Stem Cells 235
Interferon γ enhances the anti-myeloma activity of the fully human anti-HLA-DR monoclonal antibody 1D09C3 223
The anti-HLA-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing NOD/SCID mice 213
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice 211
Forced Expression of RDH10 Gene Retards Growth of HepG2 Cells 210
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor–related apoptosis-inducing ligand target both tumor cells and tumor vasculature 209
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (mTRAIL) 206
Targeting Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Agonistic Receptors for Cancer Therapy 193
Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells 193
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 184
Antitumor activity of adenovirally transduced CD34+ cells expressing membrane-bound TRAIL 183
In Vitro and In Vivo Anti-Lymphoma Activity of the Anti-HLA-DR Monoclonal Antibody 1D09C3 175
Dissection of the cord blood stromal component reveals predictive parameters for culture outcome 172
Placental Growth Factor-1 Potentiates Hematopoietic Progenitor Cell Mobilization Induced by Granulocyte Colony-Stimulating Factor in Mice and Nonhuman Primates 169
Antitumor Activity of Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (mTRAIL) 169
Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress™ Reagent 167
Primary Plasma Cells Expressing CD52 Are Efficiently Targeted In Vivo by Alemtuzumab 161
The HLA-DR-specific monoclonal antibody 1D09C3 exerts a potent antitumor activity on malignant lymphoid cells both in vitro and in vivo 155
Defining the identity of human adipose-derived mesenchymal stem cells 152
Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor 127
Uso di cellule staminali geneticamente modificate ad esprimere TNF-RELATED apoptosis-inducing ligand (TRAIL) per il trattamento di linfomi disseminati 90
null 74
Totale 4.138
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.127
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.127
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021106 0 0 0 0 0 0 0 0 0 0 85 21
2021/2022251 31 9 12 16 9 28 16 5 14 25 17 69
2022/2023406 49 61 35 48 45 81 5 27 43 0 11 1
2023/2024185 3 16 13 5 78 6 6 9 3 4 17 25
2024/2025514 13 51 6 63 32 9 23 71 19 70 41 116
2025/20261.026 128 56 112 94 127 79 132 56 71 100 71 0
Totale 4.138